APA (7th ed.) Citation

Wang, L., Wu, L., Li, X., Zhang, Y., Lai, J., Zhu, X., . . . Peng, L. (2021). Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: A study protocol for a randomised controlled trial. BMJ open, 11(8), e048410. https://doi.org/10.1136/bmjopen-2020-048410

Chicago Style (17th ed.) Citation

Wang, Lu, Lina Wu, Xuejun Li, Ying Zhang, Jing Lai, Xiang Zhu, Chan Xie, and Liang Peng. "Tenofovir Alafenamide Fumarate Therapy in Subjects with Positive HBV-DNA and Normal Levels of Alanine Transaminase: A Study Protocol for a Randomised Controlled Trial." BMJ Open 11, no. 8 (2021): e048410. https://doi.org/10.1136/bmjopen-2020-048410.

MLA (9th ed.) Citation

Wang, Lu, et al. "Tenofovir Alafenamide Fumarate Therapy in Subjects with Positive HBV-DNA and Normal Levels of Alanine Transaminase: A Study Protocol for a Randomised Controlled Trial." BMJ Open, vol. 11, no. 8, 2021, p. e048410, https://doi.org/10.1136/bmjopen-2020-048410.